|
Division of
Nephrology
Abbey Y,
Chidambaram M, Basnakian AG, Walker RB. Antioxidant
capacity measurement of aminothiol radioprotectors and their
zinc chelates. Proceedings of the 2nd
BioNanoTox Meeting. Little Rock, AR. 2007 April 26-27; IIIB:32.
Abstract.
Alam MG, Shah SV.
Approach to the patient with renal disease. In: Cecil's
Essentials of Medicine; 6th ed., WB Saunders, 2004, editors,
Andreoli TE, Carpenter CJ, Griggs RC, Loscalzo JC, Chapter 25,
pp 237-242.
Andreoli TE.
Edematous states. In: Nephrology, Hypertension, Dialysis,
Transplantation. Proceedings of the Budapest Nephrology
School. T. E. Andreoli, E. Ritz and L. Rosivall, Editors.
Hungarian Kidney Foundation. pp. 261‑277, 2005.
Andreoli, TE.
The hyperkalemic syndromes. In: Nephrology, Hypertension,
Dialysis, Transplantation. Proceedings of the Budapest
Nephrology School. T. E. Andreoli, E. Ritz and L. Rosivall,
Editors. Hungarian Kidney Foundation. pp. 279‑289, 2005.
Andreoli TE, Carpenter CCJ, Griggs RC, Benjamin IJ, editors.
Andreoli and Carpenter’s Cecil
Essentials of Medicine.
Seventh Edition. Philadelphia,
PA: Saunders Company; 2006. 1258 p.
Andreoli TE, Safirstein RL. Fluid
and electrolyte disorders. In: Andreoli TE, Carpenter CCJ, Griggs RC, Benjamin IJ, editors.
Andreoli and Carpenter's Cecil Essentials of Medicine.
Seventh Edition. Philadelphia, PA:
Saunders; 2007. p. 285-303.
Apostolov EO,
Basnakian AG, Ok E,
Shah SV.
Quantification of carbamylated LDL in
human sera
using new sandwich ELISA assay. Clin Chem 2005;
51(4):719-728.
Apostolov EO, Basnakian AG,
Ok E, Shah SV. Carbamylated
LDL enhances monocyte adhesion to endothelial cells through
ICAM-1 and VCAM-1 expression. Proceedings of the 28th
ASN Annual Meeting, Philadelphia, PA, Nov 7-13, 2005, J Am Soc
Nephrol 2005;16, 18A.
Apostolov EO,
Abu Al-Soud W, Nilsson I., Kornilovs’ka IN, Usenko VS, Lyzogubov
VV, Gaydar YuA, Wadström T, Ljungh Ĺ. Helicobacter pylori and other
Helicobacter species in gallbladder and liver of patients with
chronic cholecystitis detected by immunological and molecular
methods. Scan J Gastroenetrology 2005; 40:96-102.
Apostolov EO,
Basnakian AG, Ok E,
Shah SV. Carbamylated LDL
enhances monocyte adhesion to endothelial cells through ICAM-1
and VCAM-1 expression. Proceedings of the 28th ASN
Annual Meeting, Philadelphia, PA, Nov 7-13. J Am Soc Nephrol
2005; 16, 18A.
Apostolov EO,
Basnakian AG, Yin X,
Shah SV. Lipoprotein carbamylation is
induced by chronic renal failure in mice. Proceedings of the
29th ASN Annual Meeting. San Diego, CA. 2006 Nov
14-19; J Am Soc Nephrol 2006;17: 657A.
Apostolov EO,
Basnakian AG, Yin X, Ok E,
Shah SV. Modified LDLs induce
proliferation-mediated death of human vascular endothelial cells
through the mitogen-activating protein kinases (MAPK) pathway.
Am J Physiol Heart Cardiovasc 2007; 292(4): H1936-H1846.
Apostolov
EO, Shah SV, Ok E, Basnakian AG. Carbamylated LDL induces
monocyte adhesion to endothelial cells through ICAM-1 and
VCAM-1. Arterioscler Thromb Vasc Biol 2007; 27(4):826-32.
Apostolov
EO, Basnakian AG, Ok E, Shah SV. Carbamylated LDL and oxidized
LDL induce proliferation-mediated death of human vascular
endothelial cells. Am J Phys: Heart Vasc Circ 2007;
292(4):H1836-46.
Apostolov EO, Shah SV, Ok
E, Basnakian AG. Carbamylated LDL induces monocyte adhesion to
endothelial cells through ICAM-1 and VCAM-1. Arterioscler Thromb
Vasc Biol 2007; 27(4):826-32.
Arany I,
Megyesi J, Price PM, and
Safirstein RL. Cisplatin-induced
cell death is EGFR/src/ERK signaling dependent in mouse proximal
tubule cells. Am J Physiol Renal Physiol 2004;
287(3):F543-9.
Arany, I,
Megyesi J, Reusch J,
Safirstein RL. CREB mediates
ERK-induced survival of mouse renal tubular cells after oxidant
stress. Kidney International 2005; 68(4), 1573-1582.
Arany I,
Megyesi JK, Reusch JEB,
Safirstein RL. CREB mediates ERK-induced survival of
mouse renal tubular cells after oxidant stress. J Am Soc
Nephrol 2005; 16, 396A.
Arany I, Megyesi J, Nelkin BD,
Safirstein RL. STAT3 attenuates EGFR-mediated ERK
activation and cell survival during oxidant stress in mouse
proximal tubular cell. Kidney Int 2006; 70: 669-674.
Arany I.,
Megyesi JK, Safirstein RL. Crosstalk between ERK and STAT3
signaling in mouse proximal tubular cells during oxidant injury.
23rd Congress of the American Society of Nephrology. J Am Soc Nephrol 2006; 17: 682A.
Baliga R,
Alam M.
Shah, SV. Beneficial effect of
iron chelator administered in established nephrotic syndrome.
Proceedings of the 28th ASN Annual Meeting, Philadelphia, PA,
Nov 7-13, 2005, J Am Soc Nephrol 2005;16, 422A.
Banfalvi G, Gacsi
M, Nagy G, Kiss ZB,
Basnakian AG. Common pathway of chromosome condensation in
mammalian cells. DNA & Cell Biol 2006; 25(5): 295-301.
Banfalvi G,
Gacsi M, Nagy G, Kiss ZB, Basnakian AG.
Cadmium induced apoptotic changes in chromatin structure and
subphases of nuclear growth during the cell cycle in CHO cells.
Apoptosis 2005; 10, 3, 631-642.
Banfalvi G, Nagy
G, Basnakian AG. Supranucleosomal organization of chromatin
fibers in nuclei of Drosophila S2 cells. DNA & Cell Biol 2007;
26(1): 55-62.
Basnakian AG, Kaushal GP, Ueda N,
Shah SV. Oxidant
mechanisms in toxic acute renal failure. In: Toxicology of the
Kidney. 3d Edition. Ed, Joan B. Tarloff and Lawrence H. Lash,
499-524. Taylor & Francis, Philadelphia, 2004.
Basnakian AG,
Apostolov EO, Yin X,
Napirei M, Mannherz HG, Shah SV.
Cisplatin
nephrotoxicity is mediated by DNase I. J Am Soc Nephrol
2005; 16(3)697-702.
Basnakian AG,
Yin X,
Apostolov
EO,
Kolomeichuk SN, Stewart AG,
Shah SV.
Endonuclease G is induced and mediates ceramide cytotoxicity to
renal tubular epithelial cells.
Proceedings of
the 28th ASN Annual Meeting, Philadelphia, PA, Nov
7-13, 2005.J Am Soc Nephrol 2005; 16, 625A.
Basnakian AG, Ueda N,
Hong X, Galitovsky VE, Yin X, Shah SV.
Ceramide synthase is essential for endonuclease-mediated death
of renal tubular epithelial cells induced by hypoxia-reoxygenation.
Am J Physiol Renal Physiol 2005; 288, 2, F308-F314 (Epub
2004 Oct 12).
Basnakian AG,
Apostolov EO, Wang X, Yin X, Buzder T, Stewart AG,
Shah SV.
Inactivation of endonuclease G protects tubular epithelium from
cisplatin and ceramide injuries. Proceedings of the 29th
ASN Annual Meeting. San Diego, CA. 2006 Nov 14-19; J Am Soc Nephrol
2006; 17: 709A.
Basnakian AG,
Apostolov EO, Ok E, Yin X, Altunel E,
Shah SV. Carbamylated LDL
but not oxidized LDL is associated with atherosclerosis in
uremic patients. XLIII ERA-EDTA Congress. Glasgow, United
Kingdom. 2006 July 15-18.A #MP400. Abstract.
Basnakian
AG, Apostolov EO, Yin X, Abiri SO, Stewart AG, Singh AB,
Shah SV. Endonuclease G promotes cell death of non-invasive human
breast cancer cells. Exp Cell Res 2006; 312(20):4139-4149.
Basnakian AG, Sweatman TW, Wortsman
J, Elsner P, Slominski A Melatonin increases survival of HaCaT
keratinocytes by suppressing UV induced apoptosis, J Pineal Res
2006; 40(1): 18-26.
Basnakian AG.
Carbamylated LDL induces monocyte adhesion to endothelial cells
[Internet].
International
Atherosclerosis Society. http://www.athero.org.
Basnakian AG,
Apostolov EO, Wang X, Buzder T, Yin X, Stewart AG, Banfalvi G,
Shah SV. Enzymatic DNA
damage: the point of no return in toxic cell death. Proceedings
of the 2nd BioNanoTox
Meeting. Little Rock, AR. 2007 April 26-27: 24. Abstract.
Brosnahan G. Update of the PKD
Foundation's Booklet ,The Family and PKD: A Guide for Children and Parents [Internet].
PKD Foundation; 2006.
http://www.pkdcure.org.
Brosnahan GM. Volume progression
in polycystic kidney disease. N Engl J Med 2006;355: 733-734.
Buzder T, Yin X,
Banfalvi G, Basnakian AG. Inactivation of transfected DNA in
kidney tubular epithelial cells by cytotoxic endonucleases.
Proceedings of the 2nd BioNanoTox Meeting. Little
Rock, AR. 2007 April 26-27; IIIC: 32.Abstract.
Couser WG,
Shah SV, World Kidney Day 2007 Steering Committee,
Kopple J, Beerkens, Wilson A,
Feehally J, Reiser T, Riella M. A call to action on World Kidney
Day, March 8 2007. Nephrology 2007; 12 (1): 1–2;
J
Am Soc Nephrol 2007; 18:374-378; Am J
Kidney Dis 2007; 49:175-79; Pediatr Nephrol 2007; 3:321-325.
Ecder T,
Fick-Brosnahan GM, Schrier RW. Polycystic kidney disease. In: Schrier R, editor.
Diseases of the Kidney. 8th edition.
Philadelphia, PA: Lippincott Williams & Wilkins. p. 502-539.
Fang, Y., Megyesi J,
Safirstein RL, Price PM. Identification of the
functional domain of p21 that protects from cisplatin
cytotoxicity. Am J Physiol Renal Physiol 2005;
289:F514-20.
Fischer TW, Zbytek B, Sayre RM,
Apostolov EO, Basnakian AG, Sweatman TW,
Wortsman J, Elsner P, Slominski A. Melatonin increases survival
of HaCaT keratinocytes by suppressing UV-induced apoptosis. J
Pineal Res 2006 Jan;40(1):18-26.
Gacsi M, Nagy G, Pinter G, Basnakian
AG, Banfalvi G. Condensation of interphase
chromatin in nuclei of synchronized Chinese hamster ovary
(CHO-K1) cells. DNA and Cell Biology 2005;24, 1, 43-53.
Garg M.
Shaver MJ, Easom A. Pica. An
underappreciated cause of electrolyte abnormalities.
Nephrology News & Issues 2004;18(5):28-9, 33.
Gilbert,K.M., S.R.Boger,
Price P, and E.K.Fifer.
2005. T cell tolerance induced by histone deacetylase inhibitor
is mediated by p21cip1. Immunopharmacol Immunotoxicol 2005; 27: 545-564.
Hansberry MR,
Whittier WL, Krause MW. The
elderly patient with chronic kidney disease. Advances in Chronic
Kidney Disease. Advances in Chronic Kidney Disease 2005;
12(1):71-77.
Herberth Z,
Jones C, Bursac B,
Woods CL, Tricot G. Comparison of Five Measures Of Estimated GFR In Patients With
Multiple Myeloma. American Society of Nephrology Annual Meeting. San Diego, CA. 2006
November. Abstract.
Herzog C, Kaushal GP, and
Haun RS, Generation of biologically active interleukin-1 by
meprin B. Cytokine 2005; 31 394-403.
Herzog, C, Haun,
RS, Shah SV, and
Kaushal GP. Meprin A and B
can cleave the proinflammatory caspase-1 substrate
prointerleukin-1-beta to a biologically active mature form.
Presented at ASN, Nov 2005. J Am Soc Neph 2005; 16: 194A.
Herzog C, Haun RS,
Shah SV,
Kaushal GP. Cytokine Processing by Recombinant Meprin  and  and by Meprin a Purified from
Kidney. Proceedings of the 39th ASN Annual Meeting.
San Diego, CA. 2006 Nov. 14-19.
Herzog C, Seth R,
Shah SV,
Kaushal GP. Protective Effects of Meprin a Inhibition by
Actinonin in Cisplatin-Induced Renal Injury.
Proceedings of the 39th ASN Annual Meeting. San
Diego, CA. 2006 Nov. 14-19.
Herzog, C,
Seth R, Shah SV, and Kaushal GP. Role of meprin A in renal
tubular epithelial cell injury. Kidney Int 2007; 71:1009-1018.
Jones CA,
Krowlewski AS, Rogus J, Xue JL, Collins A, Warram JH.
Perspectives in
Renal Medicine: Epidemic of end-stage renal disease in people
with diabetes in the United States population: Do we know the
cause? Kidney Int 2005 May;67(5)1684-91.
Kaushal GP, Portilla D, and
Shah SV. Antiapoptotic Agents. In:
Ronco C, Bellomo R, Kellum J, editors. Critical Care Nephrology. 2nd
Edition. Philadelphia, PA: Exselvier; 2007.
Kaushal GP.
Liu L. Kaushal V.
Hong X. Melnyk O. Seth R. Safirstein R.
Shah SV. Regulation of caspase-3 and -9 activation in
oxidant stress to RTE by forkhead transcription factors, Bcl-2
proteins, and MAP kinases. American Journal of Physiology -
Renal Fluid & Electrolyte Physiology 2004;
287(6):F1258-68.
Kaushal GP,
Basnakian AG, Shah SV. Apoptotic pathways in ischemic
acute renal failure. Kidney International 2004;
66(2):500-6.
Kaushal V, Kaushal GP,
Mehta P: Differential toxicity of anthracyclines on cultured
endothelial cells. Endothelium 2004; 11: 253-258.
Kaushal GP, Elbein A. The
Extracellular Matrix. In: Medical Biochemistry, 2nd
Edition (Baynes, J and Dominiczak, M Eds), p.387-398, Mosby
Press, London. 2004.
Krause MW,
Massing M, Kshirsagar A, Rosamond W, Simpson R. Cardioprotective
therapy improves survival after acute myocardial infarction in
the elderly with chronic kidney disease. Renal Failure
2004; 26(6):715-725.
Krause MW,
Shah SV. Pregnancy complicated by Renal Disorders.
Chapter in Clinical Obstetrics: The Fetus and Mother, 3rd
Edition. Blackwell Publishing, 2005.
Krause MW,
Walker PD. Glomerular Diseases. Chapter in Andreoli and
Carpenter’s Cecil Essentials of Medicine VII, WB Saunders
Publishing, 2005.
Krause MW,
Shah SV. Approach to the Patient with Renal
Disease. Chapter in Andreoli and Carpenter’s Cecil Essentials
of Medicine VII, WB Saunders Publishing, 2005.
Krause MW. Evaluation of kidney
function, Nephrolithiasis, Tubulointerstitial Disorders. Sections of Medical Knowledge
Self Assessment Program (MKSAP) 14. American College of Physicians, 2006.
Krause MW, Alam M.
Peritoneal Dialysis Solutions, UptoDate, 2006.
www.uptodate.com.
Krause MW, Walker PD. Glomerular
Diseases. In: Andreoli TE,
Carpenter CCJ,
Griggs RC, Benjamin IJ, editors.
Andreoli and Carpenter's Cecil Essentials of Medicine.
Seventh Edition. Philadelphia, PA: Saunders; 2007.
Krause MW, Shah SV. Approach to
the Patient with Renal Disease. In: Andreoli TE, Carpenter CCJ, Griggs RC, Benjamin IJ,
editors. Andreoli and Carpenter's Cecil Essentials of
Medicine. Seventh Edition. Philadelphia,
PA: Saunders; 2007. p. 278-284.
Krause MW, Shah SV. Pregnancy complicated by renal disorders.
In: Reece AE, Hobbins J, editors. Clinical Obstetrics: the Fetus & Mother. 3rd
Edition. Oxford, UK: Blackwell Publishing Ltd.;
2007.
Kumar
J, Shaver MJ, Abul-Ezz S. Long-term remission of
recurrent Parvovirus-B-associated anemia in a renal transplant
recipient induced by treatment with immunoglobulin and positive
seroconversion. Journal of Transplant Infectious Diseases
2005; 7(1) :30-33.
Kumar J, Shah SV.
Kidney disease as an independent risk factor for cardiovascular
events. J Re Nutr 2005; 15(1):99-104.
Li S,
Basnakian A, Bhatt R,
Megyesi J, Gokden N. Shah SV,
Portilla D. PPAR-alpha ligand ameliorates acute renal
failure by reducing cisplatin-induced increased expression of
renal endonuclease G.A J Physiol - Renal Fluid & Electrolyte
Physiology 2004;287(5):F990-8.
Li S, Gokden N, Okusa M, Bhatt R,
Portilla
D.
Anti-inflammatory effect of fibrate protects from cisplatin
induced ARF. Am J of Physiol Renal Physiol 2005; 289:
F469-F480.
Malik B,
Abul-Ezz
S, Kumar S. Rituximab in treatment of refractory lupus
nephritis.American Society of
Nephrology Congress. San Diego, CA. 2006 Nov. Abstract.
Mehta RL, Kellum JA,
Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A.
Acute
Kidney Injury Network (AKIN): report of an initiative to improve
outcomes in acute kidney injury.
Crit Care 2007;
11(2):R31.
Mitchell
LA, Bradsher RW Jr, Paden TC, Malak SF, Warmack TS, Nazarian SM,
Fitzgerald RT, Bansal D, Carrouth DA, Khan MA,
Shah SV.
Tularemia induced bilateral optic neuritis. J Ark Med Soc 2006;
102(9):246-9.
Nádasi E, Ember I,
Arany I. Extracellular signal Regulated kinase as biomarker in the
molecular epidemiology of human carcinogenesis. IIIrd
Congress of the Society of the Hungarian Molecular and
Predictive Epidemiology. Pécs, Hungary, 2006 November 3-4.
Hungarian Epidemiology. 2006; III: S11.Abstract.
Nádasi E, Ember I,
Arany I.
Effect of a plant-originated natural compound Flavin7 extract extracellular signal regulated
kinase in immortalized mouse proximal tubule cells. IIIrd
Congress of the Society of the Hungarian
Molecular and Predictive Epidemiology. Pécs, Hungary. 2006 November 3-4. Hungarian
Epidemiology. 2006; III: S14. Abstract.
Nádasi E,
Anga B, Sándor J, Megyesi J, Kelemen D, Mottolese M, Natali PG,
Hegedüs G, Arany I, Ember I. Prognostic factors in Hungarian
breast cancer patients. Anticancer Res 2007; 27: 279-282.
Nagothu KK., Bhatt
R, Kaushal GP, Portilla D Fibrate prevents cisplatin-induced
proximal tubule cell death. Kid Int 2005; 68:
2680-2693.
Nagy G. Gacsi M. Rehak M.
Basnakian AG. Klaisz M.
Banfalvi G. Gamma irradiation-induced apoptosis in murine pre-B
cells prevents the condensation of fibrillar chromatin in early
S phase. Apoptosis 2004; 9(6):765-76.
Napirei M, Basnakian AG, Apostolov EO, Mannherz HG.
Deoxyribonuclease 1 aggravates
acetaminophen-induced liver necrosis in male CD-1 mice.
Hepatology 2006; 43(2):297-305.
Negishi K., Noiri E, Sugaya T,
Fujita T, Li S, Megyesi J, Nagothu K,
Portilla D.
Role of Liver-Fatty Acid Binding Protein in cisplatin-induced
acute renal failure. J Am Soc Nephrol 2006; 17: 527A.
Németh A, Nádasi
E, Gyöngyi Z, Olasz L, Nyárády Z, Ember Á, Kvarda A, Bujdosó L,
Arany I, Kiss I, Csejtey I,
Ember I. Early effects of different cytostatic protocols for
head and neck cancer on oncogene activation in animal
experiments. Anticancer Res 2004; 23, 4831-4836.
Ok
E, Basnakian AG, Apostolov EO,
Barri YM, Shah SV.
Carbamylated LDL induces
proliferation
and death of endothelial cells: a link to atherosclerosis.
Kidney Int, 2005, 68:1–6.
Owda A, Alam MG, Kumar J.
Cinacalcet for secondary hyperparathyroidism in patients
receiving hemodialysis. New Eng J Med 2004;
351(2):188-9.
Panesar M,
Kumar J, Abul-Ezz S.
Outcome of renal transplantation from older donors. (letter).
NEJM. 354(19): 2072, 2006.
Portilla D.,
R.Bhatt, Megyesi J,
L.Schnackenberg, Safirstein RL,
and R.D.Beger.
2005. Metabolic syndrome in acute renal failure. Role of fibrate.
J Am Soc Nephrol 2005;16:
189A.
Portilla D.,
Shaver Mary J.
Acute Renal Failure. In: Cecils Essentials of Medicine,
6th Edition. Thomas E. Andreoli, Editor. Chapter 30,
pp 291-299, 2004.
Portilla D, Okusa
M.D. T cells and Tcell receptors in acute renal failure. Kid
Int 2006; 69:208-210.
Portilla D,
Li S, Nagothu KK,
Megyesi J, Kaissling B, Schackenberg L,
Safirstein RL, Beger RD. Metabolomic study of cisplatin-induced
nephrotoxicity. Kid Int 2006; 69: 2194-2204.
Portilla D, Kaushal GP, Basnakian AG,
Shah SV. Recent Progress
in the Pathophysiology of Acute
Renal Failure, In: Marschall S, Peterson R, Peterson C, editors.
Principles of Molecular Medicine. Second Edition. Totawa, NJ: Humana Press, Inc. 2006.
p. 643-649.
Portilla D,
Andreoli TE. Disorders of Extracellular Volume. In: Richard J
Johnson, editor. Textbook of
Nephrology.
2006.
Portilla D, Andreoli TE.
Disorders of extracellular volume. In: Johnson RJ, Feehally J.
editors.Comprehensive Clinical
Nephrology. London:
Mosby International. 2007. p. 77-91.
Portilla D, Shah
SV. Acute Renal Failure. In: Andreoli TE, Carpenter CCJ, Griggs RC, Benjamin IJ, editors. Andreoli and
Carpenter's Cecil Essentials of Medicine. Seventh Edition.
Philadelphia, PA: Saunders; 2007.
Portilla D, Shah SV. Acute
kidney injury. In: Andreoli TE, Carpenter CCJ, Griggs RC, Benjamin IJ, editors. Andreoli and
Carpenter's Cecil Essentials of Medicine. Seventh Edition.
Philadelphia, PA:
Saunders; 2007. p.
332-341.
Price PM, Megyesi J, Safirstein RL.
Cell cycle regulation: repair and regeneration in acute renal
failure. Kidney Int 2004; 66(2):509-14.
Price PM
Diabetes: Caught in the Akt? Kidney Int 2007; 71: 839-841.
Roszer T,
Kappelmayer J, Nagy GG, Szentmiklosi AJ,
Basnakian AG, Banfalvi
G. The neuropeptide FMRF amide can protect cells against cell
death in the snail digestive gland. Apoptosis 2006; 11,
175-182.
Safirstein
RL. Acute renal failure: from renal physiology to
the renal transcriptome. Kidney Int 2004;
(91):S62-6.
Safirstein
RL. Pathophysiology of Acute Renal Failure.In:
Primer on Kidney Diseases, Greenburg A (eds). Academic
Press, New York. 2004.
Safirstein
RL. Renal diseases induced by anti-neoplastic agents.
In: Diseases of the Kidney, 7th edition,
Schrier
and Gottschalk’s (eds), 2005, Little, Brown and Company,
Boston, MA.
Seth R, Yang C, Kaushal V, Shah SV,
Kaushal GP. p53-dependent
caspase-2 activation
in
mitochondrial release of apoptosis inducing factor and its role
in renal tubular epithelial cell injury. J Biol Chem
2005; 280: 31230-31239.
Seth R, Yang C,
Shah SV, Kaushal
GP. Harlequin mutant mice are protected from cisplatin induced nephrotoxicity.
Proceedings of the 39th ASN Annual Meeting. San
Diego, CA. 2006 Nov.14-19.Abstract.
Shah SV.
Oxidants and iron in chronic kidney disease. Kid Int
2004;(91):S50-5.
Shah SV. Oxidants and iron in progressive kidney disease.
J
Renal Nutr 2006;16(3):185-9.
Shah
SV, Baliga R, Fonseca VA, Rajapurkar M. Oxidants in chronic
kidney disease. J Am Soc Nephrol 2007; 18(1):16-28.
Swaminathan S
and Nelson Leung. Nephrogenic Fibrosing Dermopathy: Lessons from
the past. Int J Dermatol 2006; 45: 639-41.
Swaminathan S, Ahmed I,
McCarthy JT, et al. Nephrogenic fibrosing dermopathy is high
dose erythropoietin therapy. Ann Intern Med 2006;
145:234-5.
Swaminathan S, Lager D, Leung
N, et al. Changing incidence of glomerulonephritis in Olmsted
County, Minnesota: A 30 year renal biopsy study. Clin J Am
Soc Nephrol 2006; 1:483-86.
Swaminathan S, Lager DJ, Qian
X, Stegall MD, Larson TS, Griffin MD. Collapsing and non on-collapsing focal segmental glomerulosclerosis in kidney
transplants. Nephrol Dial Transplant 2006; 21:2607-2614.
Tiwari MM, Brock RW, Megyesi
JK, Kaushal GP, Mayeux PR. Disruption of
renal peritubular blood flow in lipopolysaccharide-induced renal
failure: Roles of nitric oxide and caspases. Am J Physiol
Renal Physiol 2005; 68(6):2680-93.
Walker RB, Buzder
T., Walker DE, Abbey Y, Chidambaram M, Yin Y,
Apostolov EO,
Sorenson JRJ, Basnakian
AG. Zinc chelates of aminothiols as potential radioprotectors.
Proceedings of the 2nd
BioNanoTox Meeting. Little Rock, AR. 2007 April 26-27; 21-22.
Abstract.
Wangila GW, Nagothu KK, Steward R
3rd, Bhatt R, Lyere PA, Willingham WM, Sorenson JR, Shah SV,
Portilla D. Prevention of cisplatin-induced kidneyepithelial
cell apoptosis with a Cu superoxide dismutase-mimetic [copper
211(3,5 ditertiarybutylsalicylate)(4)ethanol4]. Toxicol In
Vitro 2006; 20(8):1300-12.
Xu-Ping Wang,
Agnes B. Fogo, Selene Colon, Giovanna Giannico,
Sameh R. Abul-Ezz, Jeffrey
H. Miner, And Dorin-Bogdan Borza. Distinct Epitopes for Anti-Glomerular
Basement Membrane Alport Alloantibodies and Goodpasture
Autoantibodies within the Noncollagenous Domain of ( alpha)
3(IV) Collagen: A Janus-Faced Antigen. Journal of the
American Society of Nephrology 2005; 16 ( 12): 3565-3571.
Yang C, Kaushal
V, Seth R, Shah SV,
Kaushal GP. Direct
transactivation of
inflammatory and ER-stress associated caspases by p53 and its role in cisplatin-
induced acute renal
failure. Presented at ASN, Nov 2005. J Am Soc Neph
2005;16:
620A.
Yang C,
Kaushal VP, Seth R, Haun
R, Shah SV, Kaushal GP. Transcription Factor p53 Regulates Caspase-7 Activation by
Physically Binding to Its Intron Sequence in Cisplatin-Induced
Acute Renal Failure. Proceedings of
the 39th ASN Annual Meeting. San Diego, CA. 2006 Nov.
14-19.
Yang C, Kaushal VP, Shah SV,
Kaushal GP. Mcl-1 Antagonizes Cisplatin-Induced Apoptosis in Renal Tubular Cells: Role of
Proteasomes and Caspases Inhibitors. Proceedings of the 39th
ASN Annual Meeting. San Diego, CA.
2006 Nov. 14-19.
Yang C,
Kaushal V, Shah SV, Kaushal GP. Mcl-1 is downregulated in
cisplatin-induced apoptosis, and proteasome inhibitors restore
Mcl-1 and promote survival in renal tubular epithelial cells. Am
J Physiol Renal Physiol 2007; 292(6):F1710-1717.
Yin X,
Apostolov EO, Shah SV,
Stewart AG, Basnakian AG.
Endonucleases are essential for kidney failure during
glycerol-induced rhabdomyolysis in mice. Proceedings of the 28th
ASN Annual Meeting, Philadelphia, PA, Nov 7-13, 2005. J Am
Soc Nephrol 2005;16, 621A.
Yin X, Apostolov EO, Wang X, Buzder T, Stewart AG,
Shah SV, Basnakian AG.) Protection against non–apoptotic cell death
during glycerol-induced kidney injury by inactivation of
apoptotic endonucleases. Proceedings of
the Keystone Meeting on Apoptotic and Non-apoptotic Cell Death.Monterey, CA. 2007 April 15-17;
142 #112. Abstract.
Yu,F.,
Megyesi J,
Safirstein RL, and Price
PM.
Cisplatin cytotoxicity is dependent on cdk2 activity. J Am
Soc Nephrol 2005; 16:
620A.
Yu,F.,
Megyesi J, Safirstein RL, Price
PM. Identification of the
functional domain of p21WAF1/Cip1 that protects from
cisplatin cytotoxicity. Am J Physiol Renal Physiol
2005; 289: F514-F520.
(Subject of Editorial Focus:Nath,K.A. 2005. The provenance of
the protective property of p21. Am J Physiol Renal Physiol
289: F512-F513).
Yu F, Megyesi J, Safirstein RL,
Price P. Cisplatin
cytotoxicity is dependent on cdk2 activity. Cold Spring Harbor
2006 Meeting on the Cell Cycle. 2006. Abst. 239.
Yu F,
Megyesi J, Price PM. Cytoplasmic initiation of cisplatin cytotoxicity.
J Am Soc Nephrol 2006; 17: 680A.
|
